In vitro activity of dermaseptin S4 derivatives against genital infections pathogens

Regulatory Toxicology and Pharmacology

Volumn 50, Issue 3, 2008, Pages 353-358

  Zairi, Amira ^a   Tangy, Frédéric ^b   Saadi, Souhir ^a   Hani, Khaled ^a  

^a UNIVERSITY OF SOUSSE   (Tunisia)

^b INSTITUT PASTEUR   (France)

Author keywords

Antimicrobial peptides; Candida albicans; Dermaseptins; Sexually transmitted diseases

Indexed keywords

DERMASEPTIN K4S4(1-16) DERIVATIVE; DERMASEPTIN K4S4(1-28) DERIVATIVE; DERMASEPTIN S4 DERIVATIVE; DERMASEPTIN S4(6-28) DERIVATIVE; DERMASEPTIN S4A DERIVATIVE; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; GENITAL TRACT INFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL;

ADULT; AMINO ACID SEQUENCE; AMPHIBIAN PROTEINS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; CELL SURVIVAL; FEMALE; FUNGI; GENITAL DISEASES, FEMALE; HELA CELLS; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; STRUCTURE-ACTIVITY RELATIONSHIP;

ANURA; CANDIDA ALBICANS; FUNGI;

EID: 41949083176     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2008.01.005     Document Type: Article

References (34)

1. Andrès E., and Dimarq J.L. Peptides antimicrobiens cationiques: de l'étude de l'immunité innée à la production des médicaments. Mise à jour. Med. Mal. Infect. 37 (2007) 194-199
2. Belaid A., Aouni M., Khelifa R., Trabelsi A., Jemmali M., and hani K. In vitro antiviral activity of dermaseptins against herpes simplex virus type I. J. Med. Virol. 66 (2002) 229-234
3. Coote P.J., Holyoak C.D., Bracey D., Ferdinando D.P., and Pearce J.A. Inhibitory action of truncated derivative of the amphibian skin peptide dermaseptin S3 on Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 42 (1998) 2160-2170
4. Corzo P., Escoubas P., Villags E., Barnaham K.J., Norton R., and Naka T. Characterization of unique amphipathic antimicrobial peptides from venom of scorpion Pandinus imperator. Biochem. J. 359 (2001) 35-45
5. Cruciani R.A., Barker J.L., Zasloff M., and Chen H.C. Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation. Proc. Natl. Acad. Sci. USA 88 (1991) 3792-3796
6. Cudic M., and Otvos L. Intracellular targets of antimicrobial peptide. Curr. Drug Targets 3 (2002) 101-106
7. Dagan A., Efron L., Gaidukov L., Mor A., and Ginsburg H. In vitro antiplasmodium effects of dermaseptins. Antimicrob. Agents Chemother. 46 (2002) 1059-1066
8. Efron L., Dagan A., Gaidukov L., Ginsburg H., and Mor A. Direct interaction of dermaseptin S4 aminoheptanoyl derivate with intraerythrocytic malaria parasite leading to increased specific antiparasitic activity in culture. J. Biol. Chem. 277 (2002) 24067-24072
9. Feder R., Dagan A., and Mor A. Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity. J. Biol. Chem. 275 (2000) 4230-4238
10. Gaidukov L., Fish A., and Mor A. Analysis of membrane-binding properties of dermaseptin analogues: relationship between binding and cytotoxicity. Biochemistry 42 (2003) 12866-12874
11. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3 (2003) 710-720
12. Gura T. Ancient system gets new respect. Science 291 (2001) 2068-2071
13. Hancock R., and Chapple D. Peptide antibiotics. Antimicrob. Agents Chemother. 43 (1999) 1317-1323
14. Hancock R.E., and Leher R. Cationic peptides: a new source of antibiotics. Trends. Biotechnol. Rev. 16 2 (1998) 82-88
15. Hernandez C., Mor A., Dagger F., et al. Functional and structure damage in Leishmania mexicana exposed to the cationic peptide dermaseptin. Eur. J. Cell Biol. 59 (1999) 414-424
16. Jouenne T., Mor A., Bonato H., and Junter G.A. Antimicrobial activity of synthetic dermaseptins against growing and non-growing Escherichia coli cultures. J. Antimicrob. Chemother. 42 (1998) 87-90
17. Krugliak M., Feder R., Zolotarev V.Y., et al. Antimicrobial activities of dermaseptin S4 derivates. Antimicrob. Agents Chemother. 44 (2000) 2442-2451
18. Kustanovich I., Shallev D.E., Mikhlin M., Gaidukov L., and Mor A. Structural requirements for potent versus selective cytotoxicity for antimicrobial dermaseptin S4 derivates. J. Biol. Chem. 277 (2002) 16941-16951
19. Leher R.I., and Ganz T. Antimicrobial peptides in mammalian and insect host defense. Curr. Opin. Immunol. 11 (1999) 23-27
20. Levy O. Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents. Blood 96 (2000) 2664-2672
21. Lorin C., Saidi H., Belaid A., Zairi A., Baleux F., Hocini H., Hani K., and Tangy F. The antimicrobial peptide dermaseptin S4 inhibits HIV-1 infectivity in vitro. Virology 334 (2005) 264-275
22. Mor A., Nguyen V.H., Delfour A., Migliore-Samour D., and Nicolas P. Isolation, amino acid sequence and synthesis of dermaseptin, a novel antimicrobial peptide of amphibian skin. Biochemistry 30 (1991) 8824-8830
23. Mor A., and Nicolas P. Isolation and structure of novel defensive peptides from frog skin. Eur. J. Biochem. 219 (1994) 145-154
24. Mor A., Rouffaud M.A., Montagne J.J., Nguyen V.H., and Nicolas P. Natural and synthetic dermaseptins: in vitro large spectrum antimicrobial peptides. J. Mycol. Med. 3 (1993) 137-143
25. Morton C.O., Hayes A., Wilson M., Rash B.M., Oliver S.G., and Coote P. Global phenotype screening and transcript analysis outlines the inhibitory mode(s) of action of two amphibian-derived (-helical, cationic peptides on Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 51 (2007) 3948-3959
26. Naglik J.R., Rodgers C.A., Shirlaw P.J., et al. Differential expression of Candida albicans secreted aspartyl proteinase and phospholipase B genes in humans correlates with active oral and vaginal infections. J. Infect. Dis. 188 3 (2003) 469-479
27. Navon-Venezia S.N., Feder R., Gaidukov L., Carmeli Y., and Mor A. Antimicrobial properties of dermaseptin S4 derivatives with in vivo activity. Antimicrob. Agents Chemother. 46 (2002) 689-694
28. Nicolas P., and Mor A. Peptides as weapons against microorganisms in the chemical defense system of vertebrates. Ann. Rev. Microbiol. 49 (1995) 277-304
29. Qu X.D., Sylvia S.L., Oren A., Shafer W.M., and Lehrer R. Protegrin structure and activity against Neisseria gonorrhoeae. Infect. Immun. 65 (1997) 636-639
30. Ruiz J., Marco F., Sierra J.M., et al. In vitro activity of gemifloxacin against clinical isolates of Neisseria gonorrhoeae with and without mutations in the gyr A gene. Int. J. Antimicrob. Agents. 22 (2003) 73-76
31. Shephered C.M., Vogel H.J., and Tieleman D.P. Indications of the designed antimicrobial peptides MB21 and truncated dermaseptins S3 with lipid bilayers: molecular dynamics stimulations. Biochem. J. 1 (2003) 233-243
32. Silva O., Ferreira E., Pato M.V., Caniça M., and Gomes E.T. In vitro anti-Neisseria gonorrhoeae activity of Terminalia macropetra leaves. FEMS Microbiol. Lett. 211 (2002) 203-206
33. Venev S. Experimental abortions in mice and guinea pigs caused by Aspergillus fumigatus spores. Vet. Med. Nauki. 13 1 (1976) 86-93
34. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 415 (2002) 389-395